Ajaykumar Maruti Waghmare

Ajaykumar Maruti Waghmare

Director DIN 03616295
DIN 03616295 First appointment Sep 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajaykumar Maruti Waghmare

Data last updated:

Ajaykumar Maruti Waghmare was a Director at Arrow Solutions Private Limited (from 2011) and Director at Xenobiotech Healthcare Private Limited (from 2013).

DIN 03616295
First Appointment 22 Sep 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arrow Solutions Private Limited U74120MH2011PTC222284
Director22 Sep 20112011Strike Off
Director19 Dec 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arrow Solutions Private Limited
Xenobiotech Healthcare Private Limited
Premium access

Shareholding and investment profile for Ajaykumar Maruti Waghmare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajaykumar Maruti Waghmare

Ajaykumar Maruti Waghmare was first appointed on 22 Sep 2011 as Director at Arrow Solutions Private Limited. The most recent appointment on record is 19 Dec 2013 at Xenobiotech Healthcare Private Limited.

Ajaykumar Maruti Waghmare held 2 earlier board appointments: Arrow Solutions Private Limited (Director, from 22 Sep 2011); Xenobiotech Healthcare Private Limited (Director, from 19 Dec 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available